Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT.

Journal: Annals of hematology
PMID:

Abstract

Infection post-hematopoietic stem cell transplantation (HSCT) is one of the main causes of patient mortality. Fever is the most crucial clinical symptom indicating infection. However, current microbial detection methods are limited. Therefore, timely diagnosis of infectious fever and administration of antimicrobial drugs can effectively reduce patient mortality. In this study, serum samples were collected from 181 patients with HSCT with or without infection, as well as the clinical information. And more than 80 infectious-related microRNAs in the serum were selected according to the bulk RNA-seq result and detected in the 345 time-pointed serum samples by Q-PCR. Unsupervised clustering result indicates a close association between these microRNAs expression and infection occurrence. Compared to the uninfected cohort, more than 10 serum microRNAs were identified as the combined diagnostic markers in one formula constructed by the Random Forest (RF) algorithms, with a diagnostic accuracy more than 0.90. Furthermore, correlations of serum microRNAs to immune cells, inflammatory factors, pathgens, infection tissue, and prognosis were analyzed in the infection cohort. Overall, this study demonstrates that the combination of serum microRNAs detection and machine learning algorithms holds promising potential in diagnosing infectious fever after HSCT.

Authors

  • Wenwei Shao
    Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300072, China.
  • Yixuan Wang
    Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Li Liu
    Metanotitia Inc., Shenzhen, China.
  • Yiran Ren
    State Key Laboratory of Experimental Hematology, Hematopoietic Stem Cell Transplantation Center, Haihe Laboratory of Cell Ecosystem, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Jieru Wang
    Department of Critical Care Medicine, The Fifth People's Hospital of Jinan City, Jinan, China.
  • Yuqing Cui
    State Key Laboratory of Experimental Hematology, Hematopoietic Stem Cell Transplantation Center, Haihe Laboratory of Cell Ecosystem, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Jia Liu
    Department of Colorectal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin, China.
  • Xiaoyu Zhang
    First Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Sudong Zhang
    State Key Laboratory of Experimental Hematology, Hematopoietic Stem Cell Transplantation Center, Haihe Laboratory of Cell Ecosystem, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Shuangjie Liu
    Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300072, China.
  • Erlie Jiang
    State Key Laboratory of Experimental Hematology, Hematopoietic Stem Cell Transplantation Center, Haihe Laboratory of Cell Ecosystem, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Sizhou Feng
    State Key Laboratory of Experimental Hematology, Hematopoietic Stem Cell Transplantation Center, Haihe Laboratory of Cell Ecosystem, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. szfeng@ihcams.ac.cn.
  • Xiaolei Pei
    State Key Laboratory of Experimental Hematology, Hematopoietic Stem Cell Transplantation Center, Haihe Laboratory of Cell Ecosystem, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. peixiaolei@ihcams.ac.cn.